NCT02552667View on ClinicalTrials.gov

Efficacy and Safety of HCP1102 Capsule

PHASE3CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Asthma With Allergic Rhinitis
Interventions
DRUG

HCP1102+HGP0711Placebo

Coadministration of HCP1102 with HGP0711 Placebo for 4-week

DRUG

HCP1102Placebo+HGP0711

Coadministration of HCP1102 Placebo with HGP0711 for 4-week

Trial Locations (1)

Unknown

Soon Chun Hyang University Hospital Bucheon, Bucheon-si

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02552667 - Efficacy and Safety of HCP1102 Capsule | Biotech Hunter | Biotech Hunter